A Phase 2 Study of Extended Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Newly Diagnosed Multiple Myeloma

被引：0

作者：

Derman, Ben A. ^{[1
]}

Major, Ajay ^{[1
]}

Rosenblatt, Jacalyn ^{[2
]}

Avigan, David ^{[2
]}

Rampurwala, Murtuza M. ^{[1
]}

Alcantar, Luis ^{[3
]}

Libao, Bernadette M. ^{[3
]}

McIver, Amanda ^{[3
]}

Andreatos, Evangelia ^{[3
]}

Major, Sarah ^{[3
]}

Wolfe, Brittany ^{[3
]}

Gorski, Martha

Karrison, Theodore G. ^{[4
]}

Stefka, Andrew ^{[3
]}

Jakubowiak, Andrzej ^{[3
]}

机构：

[1] Univ Chicago, Hematol Oncol Sect, Chicago, IL USA

[2] Beth Israel Deaconess Med Ctr, Boston, MA USA

[3] Univ Chicago, Chicago, IL USA

[4] Univ Chicago, Dept Publ Hlth Sci, Chicago, IL USA

来源：

关键词：

D O I：

10.1182/blood-2021-151832

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5